Rationale Sex differences in the analgesic effects of muopioid agonists have been documented extensively in rodents and, to a lesser extent, in non-human primates. To date, there have been few experimental studies investigating this effect in humans, and the conclusions have been equivocal. Objectives The aims of the present study were to examine potential sex differences in the analgesic, subjective, performance, and physiological effects of morphine in human research volunteers. Methods Using a double-blind outpatient procedure, the present study investigated the effects of intramuscular morphine (0, 5, and 10 mg/70 kg, i.m.) in men (N=8) and women (N=10). The primary dependent measure was analgesia, as assessed by the cold pressor and mechanical pressure tests. Secondary dependent measures included subjective, performance, and physiological effects of morphine, as well as plasma levels of morphine. Results No differences in the analgesic and performance effects of morphine were observed between men and women, but significant differences in morphine's subjective effects were found. Specifically, men reported greater positive effects, whereas women reported greater negative effects after morphine administration. Conclusions These data suggest that, in humans, there are sex differences in the subjective mood-altering effects of morphine but, based on this limited sample, there is little evidence for sex differences in its analgesic effects.
Introduction
Morphine and other mu-opioid agonists have long been used clinically to alleviate pain. Recent findings have demonstrated sex differences in the analgesic effects of mu opioids in some species (see Craft 2003 for review). In rodents, for example, numerous studies have demonstrated that a lower dose of drug is required to produce an equivalent antinociceptive effect in males compared to females (Barrett et al. 2002; Terner et al. 2003; Stoffel et al. 2005) . In contrast, there is little evidence for such a phenomenon in non-human primates. One study showed that male rhesus monkeys were more sensitive to low-efficacy mu opioid agonists than females, but there was no sex difference in analgesic effectiveness of the high-efficacy agonist fentanyl (Negus and Mello 1999) . Although there is some evidence that partial (low-efficacy) agonists are more potent and effective for the relief of post-surgical pain in women compared with men (Gear et al. 1996 (Gear et al. , 1999 (Gear et al. , 2003 Gordon et al. 1995; Chia et al. 2002) , this sex difference has not been reliably observed in studies using laboratory pain models (Sarton et al. 2000; Fillingim and Gear 2004; Fillingim et al. 2005; Zacny and Beckman 2004; Olofsen et al. 2005) .
The current study was designed to examine potential sex differences in the effects of morphine in a controlled setting using the cold pressor test (CPT) and the mechanical pressure test (MPT) . The CPT has good predictive validity for various analgesics (Chen et al. 1989; Conley et al. 1997 ). Both tests have been used to study sex differences in response to analgesia in the absence of drug (CPT, Hellström and Lundberg 2000; Lowery et al. 2003; Dixon et al. 2004; Edwards et al. 2004; Mitchell et al. 2004; Thorn et al. 2004; Kowalczyk et al. 2006 ; but see Zacny and Beckman 2004; MPT, Brennum et al. 1989; Chesterton et al. 2003; Clark et al. 1989; Riley et al. 1998) . In most of these studies, women were more sensitive to pain than men. In the current study, we hypothesized that women would be more sensitive to the effects of morphine on both pain tests.
Methods
Participants Normal, healthy volunteers (eight men and ten women) aged 21-45 years who had taken opioids at least twice previously for medical purposes were included. Those who reported chronic pain, used over-the-counter analgesics more than four times a month, met Diagnostic and Statistical Manual of Mental Disorders (4th edition, revised) criteria for substance abuse or dependence in the past 2 years, or had current Axis I psychopathology were excluded.
Study Design and General Procedure Participants completed 12 outpatient sessions. During each session, one of three doses of morphine was administered, and pain response was assessed using either the CPT or the MPT. Each condition (pain assay and morphine dose) was tested twice, and in normally menstruating women (N=7), the two sessions were scheduled during the follicular and luteal phases of the menstrual cycle (days 2-10 and 19-27 after the onset of menstruation). Menstrual cycle phase was confirmed by measuring plasma levels of estradiol and progesterone and by using ovulation kits. Men and the three women on oral contraceptives were tested at intervals similar to the normally menstruating women. Because preliminary analyses indicated that menstrual cycle phase or oral contraceptives had little effect on responses to morphine, data from all the women were pooled. The study was conducted under double-blind dosing conditions, and the order of dose and pain test was randomized. Before testing, participants completed a training session to familiarize them with the study procedures. They were asked to refrain from using alcohol, psychoactive drugs, and over-the-counter analgesics during the 12 h prior to the session, which was confirmed with breath alcohol levels and urine drug toxicologies.
Pharmacodynamic responses were assessed, and venous blood samples were collected before and for up to 4 h after each drug administration. Capillary gas chromatography/ mass spectrometry using trideuterated morphine as an internal standard was used to assess morphine levels.
Cold pressor test The cold pressor apparatus consisted of two water coolers, filled with either warm (37ºC) or cold water (4ºC; Kowalczyk et al. 2006) . The CPT began with an immersion of the forearm into the warm-water bath for 3 min. Participants then immersed the forearm into the coldwater bath and were instructed to report the first painful sensation after immersion. They were asked to tolerate the stimulus for as long as possible but were permitted to withdraw their arm from the water if the stimulus was too uncomfortable. Latency to first feel pain (threshold) and to withdraw the arm from the water (tolerance) were recorded by the experimenter. Upon withdrawal, blood pressure was measured, and the McGill Pain Questionnaire (see below) was completed. The CPT, which took approximately 15 min to complete, was performed before and again approximately 45 and 205 min after drug administration.
Mechanical pressure test The equipment used for the MPT was modeled after the Forgione-Barber focal pressure stimulator (Glederer & Co., Inc., Paterson, NJ). Pressures of various intensities were applied to the fingers using a dull plastic tip (Lucite, 4 mm in diameter) applied at a continuous pressure. The four intensities that were tested were as follows: 2.83 N (440 g), 3.89 N (600 g), 6.02 N (780 g), and 8.76 N (955 g). Each weight was tested 12 times for a total of 48 presentations per session. The maximum exposure during each trial was 30 s, but the participant could ask the experimenter to remove the weight if the intensity of the stimulus was too great. During each trial, participants rated the intensity of the stimulus 5, 10, 20, and 30 s after the weight was placed on the finger. The rating scale ranged from "not noticeable" to "worst possible pain." Immediately following the task, the McGill Pain Questionnaire was completed. The MPT, which took approximately 40 min to complete, was performed before and approximately 35 and 185 min after drug administration.
Subjective Pain Measure: McGill Pain Questionnaire A 15-item shortened form of the McGill Pain Questionnaire (Melzack 1987 ) was used to assess the pain experience immediately following the CPT and MPT. Responses to the 15 questions were summed and could range between 15 and 60.
Subjective Drug Effects Participants completed a six-item Drug Effects Questionnaire approximately 5, 15, 30, 60, 120, 180 , and 240 min after drug administration. They rated the drug effects according to how they were feeling at that moment on a scale ranging from "No good (bad, etc.) effects at all" to "Very much." Participants also were asked whether they liked the drug on a scale ranging from "Dislike very much" to "Like very much." An 18-item visual analog scale was completed before and approximately 115, 175, and 305 min after drug administration. Scores ranged from 0 ("Not at all") to 100 ("Extremely"). Participants also completed a 13-item Opiate Symptom Checklist Martin and Fraser 1961) , consisting of true/false questions.
Performance tasks Participants completed a 3-min digitsymbol substitution task, a 10-min divided attention task, and a 10-min rapid information-processing task before and approximately 90, 150, and 240 min after drug administration (see Comer et al. 1999 for details).
Physiological effects A blood pressure cuff was used to measure heart rate and systolic and diastolic pressure (Sentry II Vital Signs Monitor, NBS Medical). A pulse oximeter was used to continuously monitor percent SpO 2 (Model 400, Palco Laboratories). A Canon Powershot G2 camera was used to take pupil photographs under ambient lighting conditions. Blood pressure, percent SpO 2 , and pupil diameter were recorded before and 5, 15, 30, 60, 120, 180, and 240 min after drug administration.
Drugs Morphine sulfate solution (0, 5, and 10 mg/70 kg; Elkin-Sinn, Inc.) was injected into the deltoid muscle in a total volume of 1 cc. Doses used clinically for acute pain are 5-30 mg every 4 h. The oral to parenteral dose conversion for analgesia is generally accepted to be 3:1 (Berdine and Nesbit Pain threshold was defined as latency to feel pain (0-180 s), and pain tolerance was defined as latency to withdraw the forearm from the cold water (0-180 s). Filled symbols represent a significant difference from placebo at that time point. Asterisks represent a significant difference between 5 and 10 mg/70 kg morphine. Squares represent data collected during sessions involving administration of placebo, circles represent data collected during sessions involving administration of 5 mg/70 kg morphine, and diamonds represent data collected during sessions involving administration of 10 mg/70 kg morphine 2006), so the intramuscular doses of 5 and 10 mg/70 kg used in the present study are within the upper range that is typically prescribed for the treatment of pain.
Data Analyses A mixed within-and between-subjects design was used in the current study. Pain task, morphine dose, and time served as within-subject variables and sex served as the between-subject variable. Primary dependent variables were analgesic responses. The latency to first feel pain and to withdraw the arm from the cold water served as the two primary dependent variables measured in the CPT. The ability to discriminate between two stimuli of varying intensities [P(A)] and readiness to report pain (stoicism, B) served as the two primary dependent variables measured in the MPT (Clark and Dillon 1973; Gil et al. 1996; McNicol 1972) . Secondary dependent variables included subjective, performance, and physiologic effects as a function of morphine dose and sex. Repeated measures analyses of variance (ANOVA) for within-subject variables were performed to determine effects of morphine dose and time. Planned comparisons were conducted between each of the morphine doses and between the different time points. Mixed model analyses within the MANCOVA module of Statistica were performed to examine sex differences as a function of dose and time.
Results
Participants Eighteen participants, including ten women (nine white and one black) and eight men (three white, two black, one Asian, and two other) completed the study (Table 1) . Three women reported current use of oral contraceptives. Eight volunteers reported some current alcohol use and six consumed caffeinated beverages daily. None of the participants smoked cigarettes daily or used other nicotinecontaining products. One participant reported twice monthly marijuana use. Others reported previous recreational drug use (Table 1) . Three participants began the study but were discontinued for medical reasons (one had an allergic reaction to latex, two experienced vasovagal responses to the CPT), and three discontinued because of side effects of morphine (i.e., nausea and vomiting).
Cold pressor test: threshold and tolerance Among women, morphine dose-dependently increased pain tolerance Women reported less drug liking at the highest dose of morphine compared to placebo (Fig. 4) , and they were less willing to take the drug again as dose increased [ Fig. 4 ; dose, F(2,18)=5.9, p≤0.01]. In contrast, as the dose increased, men reported greater drug liking and willingness to take the drug again. Ratings of strength of drug effect increased with increasing dose in both men and women (data not shown; p≤ 0.001 and p≤0.01 for the main effects of dose and time, respectively, in both groups), with peak ratings between "definite mild effect" and "moderately strong effect." Both men and women also reported that morphine was sedativelike (data not shown). Men reported greater willingness to take the drug again [sex×dose, F(2,32)=4.8, p≤0.05] and greater good drug effects [sex×dose, F(2,32)=5.1, p<0.01]. Fig. 4 Average subjective ratings of "drug liking" and "willingness to take the drug again" (±1 SEM) as a function of morphine dose and time after morphine administration in women (N=10) and men (N=8). Morphine affected other subjective responses to a similar extent in men and women (Table 3) . For example, on the visual analog scales, morphine decreased ratings of "able to concentrate," "alert," and "self-confident" and increased ratings of "confused," "high," and "sedated." Morphine increased VAS ratings of "bad effect" and "tired" to a greater extent in women than in men (sex×dose×time interactions; p≤0.05). Men reported greater increases in VAS ratings of "good effect" than women (p < 0.01; Table 3 ). Sum scores on the Opiate Symptom Checklist (data not shown) dose-dependently increased in both men [dose, F(2,14)=21.3, p≤0.0001] and women [dose, F(2,18)=27.0, p≤0.0001], with no between-group differences.
Performance Effects Among both men and women, morphine increased the latency to correctly identify a target (mean Table 3 Selected mean visual analog scale ratings (±1 standard error of the mean, SEM) for women (N=10) and men (N=8) averaged across the session as a function of morphine dose Arrows represent the direction of effect as a function of morphine dose a Indicates a significant difference from placebo b Indicates a significant difference between 5 and 10 mg/70 kg morphine Fig. 5 Representative cognitive effect of morphine demonstrated by performance on the divided attention task defined by average hit latency (±1 SEM) as a function of morphine dose and time after morphine administration in women (N=10) and men (N=8). Filled symbols indicate a significant difference from placebo. Asterisks represent a significant difference between 5 and 10 mg/70 kg morphine. Squares represent data collected during sessions involving administration of placebo, circles represent data collected during sessions involving administration of 5 mg/70 kg morphine, and diamonds represent data collected during sessions involving administration of 10 mg/70 kg morphine hit latency) during the divided attention task (Fig. 5 , Table 4 ; dose×time, p≤0.05). Morphine decreased total correct and total attempted patterns on the digit symbol substitution task in both men and women (Table 4 ). In addition, the number of missed targets on the rapid information processing task increased by dose and time in both men and women (Table 4 ; dose×time, p≤0.05). No sex differences were observed for any of the cognitive tasks.
Physiological effects Morphine dose-dependently decreased pupil diameter in both groups (Fig. 6, Plasma morphine levels Plasma morphine levels (data not shown) dose-dependently increased in both women [F(1,9)= 159.9, p≤0.0001] and men [F(1,7)=172.4, p≤0.0001].
Average peak morphine levels were 26.6 and 61.7 ng/ml after administration of 5 and 10 mg/70 kg morphine, respectively. No difference in morphine plasma levels as a function of sex was detected.
Discussion
Morphine produced different subjective mood effects, but similar analgesic effects in men and women in this study using two nociceptive stimuli. This absence of a sex difference in analgesia is interesting in light of the substantial evidence for sex differences in opioid analgesia in rodents (Barrett 2006) . Although women were more sensitive to opioid-induced analgesia in some studies (Fillingim and Gear 2004) , these findings appear to depend upon the type of drug and pain models used. For instance, women were more sensitive than men to three opioid agonists in the CPT but not the MPT (Zacny 2002) . In other studies, the analgesic effects of morphine were similar in men and women, using heat, pressure, and ischemic pain tests (e.g., Fillingim et al. 2005) .
Although the results of the present study are consistent with Fillingim et al. (2005) , they must be viewed with caution because of the small sample sizes in each group. Although sensitivity to morphine's analgesic effects did not differ between men and women in the present study, a robust difference in subjective ratings was observed. Women reported significantly greater negative effects after morphine administration compared to men, whereas men reported significantly greater positive drug effects. The current findings are consistent with previous reports demonstrating robust negative subjective ratings after opioid administration such as increased nausea and vomiting and higher ratings of "sluggish feeling" and "dry mouth" in women (Zacny 2001 (Zacny , 2002 Zun et al. 2002; Cepeda et al. 2003; Fillingim et al. 2005; Bijur et al. 2008) . The higher sensitivity to the subjective effects of morphine in women observed here are also consistent with the results of a previous study examining sex differences in response to experimentally induced pain as measured by positron emission tomography and [ 11 C]-carfentanil (Zubieta et al. 2002) . These investigators postulated that the higher regional (amygdala) concentrations of mu receptors in women could explain their greater sensitivity to the effects of mu opioids. It is possible that the robust negative effects of opiates in women contribute to their lower post-surgical opioid use, a finding that some have attributed to increased analgesic effects of opioids in women (Chia et al. 2002) . It also should be noted that modest sex differences in subjective ratings of drug effects have been reported with cocaine (Kosten et al. 1993; Evans et al. 1999) , tetrahydrocannabinol (Haney 2007) , nitrous oxide (Dohrn et al. 1992) , and nicotine (Eissenberg et al. 1999) , suggesting that sex differences in subjective responses may be a common phenomenon that occurs across many drug classes. However, men and women do not appear to differ on measures of performance: Morphine impaired performance on all of the tasks, consistent with previous reports in rodents Sala et al. 1994; Hepner et al. 2002) , monkeys (Rupniak et al. 1991) , and humans (Darke et al. 2000; Specka et al. 2000; Zacny and Gutierrez 2003) . Morphine altered several vital signs in the present study. Women exhibited a greater decrease in oxygen saturation after morphine administration, which is consistent with a previous report (Dahan et al. 1998) . Furthermore, in the present study, the pressor effects during the CPT were greater in men, as reported previously by Fillingim et al. (2005) . However, sex differences in morphine's physiologic effects, although statistically significant, were small and most likely not clinically relevant.
The present study had several limitations. First, the participants were healthy volunteers, and several participants withdrew from the study, and thus, it is not known whether these results would be generalizable to other populations. Second, the sample size was small, which limits the ability to interpret measures on which males and females did not differ. Fourth, we were not able to rule out the possibility of carry-over effects from repeated pain provocation and morphine administration or the possibility of conditioned effects related to repeated testing. Finally, the men and women in this study differed in age, so this variable also may have affected our outcome measures.
In summary, the findings from the present study indicate that men and women differ in their mood responses to morphine but may not differ in their sensitivity to the analgesic effects of morphine. This suggests that the two effects may be dissociable. Mood states have been shown to impact pain sensitivity, in some instances, to a greater degree in women than men Keogh et al. 2006; Garofalo et al. 2006) , so it is conceivable that aversive subjective effects would also alter the analgesic effectiveness of a medication. Attention to the negative subjective effects reported in both men and women and the possible impact of such subjective effects on analgesia should be considered when determining therapeutic doses of morphine.
